Loading clinical trials...
Loading clinical trials...
This is a multi-center, prospective, controlled study. MS patients (1° group: 30 patients in relapse; 2° group: 30 patients in remission) and age/sex-matched healthy controls (3° group: 30 subjects) w...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Regina Elena Cancer Institute
Collaborators
NCT06433752 · Relapsing Multiple Sclerosis, Multiple Sclerosis
NCT06615479 · Relapsed or Refractory Multiple Myeloma (RRMM)
NCT06846281 · Relapsing Multiple Sclerosis
NCT05100862 · Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma
NCT05644522 · Cerebrovascular Accident, Post-polio Syndrome, and more
Icahn School of Medicine at Mount Sinai
New York, New York
IRCCS Regina Elena National Cancer Institute
Rome
University of Rome Sapienza
Rome
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions